Related News »
Canadian pharmaceutical firm QLT Inc. postponed its annual general meeting after receiving a raft of late director nominations from a group of institutional investors it believes is looking to gain control of the company. QLT said its second-largest ...
May 24, 2012 at 13:34 | Source: The Vancouver Sun
(Reuters) - Canadian eye drug developer QLT Inc has not been able to communicate with the major shareholder behind a last-minute proxy campaign that spurred the company to postpone its annual meeting, QLT's chief executive told Reuters on Friday.
May 25, 2012 at 18:05 | Source: YAHOO!
VANCOUVER, British Columbia, May 24, 2012 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI - News) (TSX:QLT.TO - News) ("QLT" or the "Company") reported today that in light of the ongoing dissident shareholder activity, the management team and the ...
May 27, 2012 at 07:54 | Source: Yahoo Finance
QLT Inc. (Nasdaq: QLTI) is indicated higher following large shareholder Axial Capital Management filing an amended 13D with the U.S. SEC which said, in part: "The Reporting Persons previously filed a Schedule 13G with respect to the Shares on February 14 ...
May 25, 2012 at 10:41 | Source: StreetInsider.com
Canadian pharmaceutical company QLT Inc. said a group of institutional shareholders was looking to gain control of the company by nominating a slate of directors to its board at an annual shareholder meeting on Thursday. NB Public Equity Komplementar ApS ...
May 22, 2012 at 23:52 | Source: The Vancouver Sun
Vancouver-based QLT Inc. postponed its annual meeting on Thursday, just hours before it was scheduled to begin, after a major shareholder disclosed a proxy campaign to take control of the pharmaceutical company's board. Vancouver-based QLT Inc ...
May 25, 2012 at 08:47 | Source: Calgary Herald
VANCOUVER, British Columbia, May 24, 2012 (GLOBE NEWSWIRE) -- The Board of Directors (the "Board") of QLT Inc. (Nasdaq:QLTI - News) (TSX:QLT.TO - News) ("QLT" or the "Company"), having heard from a number of shareholders over the past 24 hours ...
May 24, 2012 at 06:25 | Source: Yahoo Finance
Another major proxy battle is brewing in Vancouver. Biotech company QLT Inc. (TSX:QLT) has issued a letter to stock holders warning of an attempt by a Danish venture capital firm to gain control of the company's board of directors at today's ...
May 24, 2012 at 17:59 | Source: Business in Vancouver
Average quality rating by the Stockhouse community. The third company on the consultant list of comparable companies to Nuvo Research (for the purposes of determining compensation) is QLT Inc. QLT Inc., a biotechnology company, engages in the development ...
May 18, 2012 at 05:28 | Source: Stockhouse
Since the company's report, shares of QLT have risen from $6.47 to $6.70, representing a gain of 3.6% in the past 15 days. QLT Inc. develops and commercializes pharmaceutical products for use in photodynamic therapy, the use of light activated drugs to treat disease.
May 18, 2012 at 20:44 | Source: Financial News Network Online